PSTV

PSTV

USD

PLUS THERAPEUTICS Inc. Common Stock

$0.509+0.009 (1.860%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$0.500

Hoch

$0.519

Tief

$0.491

Volumen

5.03M

Unternehmensfundamentaldaten

Marktkapitalisierung

70.0M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

20.11M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.16Aktuell $0.509Hoch $2.31

Ähnliche Nachrichten

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Plus Therapeutics, Lowers Price Target to $2

HC Wainwright & Co. analyst Sean Lee maintains Plus Therapeutics with a Buy and lowers the price target from $3 to $2.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Plus Therapeutics, Lowers Price Target to $2
Analyst Upgrades

D. Boral Capital Maintains Buy on Plus Therapeutics, Maintains $5 Price Target

D. Boral Capital analyst Jason Kolbert maintains Plus Therapeutics with a Buy and maintains $5 price target.

Mehr anzeigen
D. Boral Capital Maintains Buy on Plus Therapeutics, Maintains $5 Price Target
GlobeNewswire

Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights

US market introduction of the CNSide® CSF diagnostics platform, with first national coverage agreement with UnitedHealthcare Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct. 30, 2025 (GLOBE

Mehr anzeigen
Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights
GlobeNewswire

Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch

Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and technical operations HOUSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc.

Mehr anzeigen
Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch